HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Arima Genomics announced that it will present new data at the Association for Molecular Pathology (AMP) 2025 Annual Meeting.

See’s Color Calibrated Technology Significantly Increases the Accuracy of Routine Medical Photographs and Enables Development ...

Multiple presentations on vimseltinib for the treatment of Tenosynovial Giant Cell Tumor (TGCT), including encore data from the Phase 3 MOTION study presented in an oral session - Two posters on ...

Multiple presentations on vimseltinib for the treatment of Tenosynovial Giant Cell Tumor (TGCT), including encore data from the Phase 3 MOTION study presented in an oral session -- -- Two posters on ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...

BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) ...

For too long, Cybersecurity Awareness Month has served as an annual pep rally for security teams, inspiring a flurry of ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts – one oral and four ...

The Lycoming College community was well represented at the recent Pennsylvania Historical Association (PHA) Annual Meeting & ...

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 ...